Guangzhou LBP Medicine Science & Technology Co Ltd Net Asset Quality Index
Guangzhou LBP Medicine Science & Technology Co Ltd net asset quality index. Guangzhou LBP Medicine Science & Technology Co Ltd (688393) has a Net Asset Quality Index of 91.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.31 Billion minus total liabilities of CN¥113.31 Million yields net assets of CN¥1.20 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Guangzhou LBP Medicine Science & Technol for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guangzhou LBP Medicine Science & Technology Co Ltd (2011–2024)
Net asset quality index of Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024. This chart shows how Guangzhou LBP Medicine Science & Technology Co Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2011 to 2024. As of September 2025, the index stands at 91.4%, representing net assets of CN¥1.20 Billion against total assets of CN¥1.31 Billion CNY. Check Guangzhou LBP Medicine Science & Technol (688393) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Guangzhou LBP Medicine Science & Technology Co Ltd Net Asset Quality Index by Year (2011–2024)
Guangzhou LBP Medicine Science & Technology Co Ltd net asset quality index by year from 2011 to 2024. The table below presents the year-by-year Net Asset Quality Index for Guangzhou LBP Medicine Science & Technology Co Ltd from 2011 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Guangzhou LBP Medicine Science & Technol market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 90.4% | CN¥1.23 Billion | CN¥1.36 Billion | CN¥130.99 Million | ▲ +1.9 pp |
| 2023 | 88.5% | CN¥1.24 Billion | CN¥1.40 Billion | CN¥161.63 Million | ▲ +0.7 pp |
| 2022 | 87.8% | CN¥1.22 Billion | CN¥1.39 Billion | CN¥170.45 Million | ▼ -0.8 pp |
| 2021 | 88.6% | CN¥1.21 Billion | CN¥1.37 Billion | CN¥155.96 Million | ▼ -1.8 pp |
| 2020 | 90.4% | CN¥1.17 Billion | CN¥1.29 Billion | CN¥124.67 Million | ▲ +7.7 pp |
| 2019 | 82.7% | CN¥444.63 Million | CN¥537.96 Million | CN¥93.33 Million | ▲ +1.0 pp |
| 2018 | 81.7% | CN¥389.32 Million | CN¥476.56 Million | CN¥87.25 Million | ▼ -2.3 pp |
| 2017 | 84.0% | CN¥346.28 Million | CN¥412.06 Million | CN¥65.78 Million | ▼ -5.9 pp |
| 2016 | 89.9% | CN¥320.94 Million | CN¥357.02 Million | CN¥36.08 Million | ▲ +6.3 pp |
| 2013 | 83.6% | CN¥215.00 Million | CN¥257.13 Million | CN¥42.13 Million | ▼ -6.7 pp |
| 2012 | 90.3% | CN¥173.32 Million | CN¥191.92 Million | CN¥18.60 Million | ▲ +47.1 pp |
| 2011 | 43.2% | CN¥48.09 Million | CN¥111.40 Million | CN¥63.31 Million | — |